Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Oct 21;2(11):1568-9.
doi: 10.1016/j.ebiom.2015.10.014. eCollection 2015 Nov.

Linezolid for Treating Tuberculosis: A Delicate Balancing Act

Gary Maartens  1 , Constance A Benson  2
Affiliations
Comment

Linezolid for Treating Tuberculosis: A Delicate Balancing Act

Gary Maartens et al. EBioMedicine. .

Erratum in

No abstract available

PubMed Disclaimer

Comment on

References

    1. Barry P., Deck D., Farkas A. IDWeek 2014. 2014. Pharmacokinetic modeling of linezolid dosing regimens for multidrug resistant tuberculosis. (Philadelphia, PA, October 8–12; Abstr. 406)
    1. De Vriese A.S., Coster R.V., Smet J. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin. Infect. Dis. 2006;42(8):1111–1117. - PubMed
    1. Falzon D., Gandhi N., Migliori G.B. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur. Respir. J. 2013;42:156–168. - PMC - PubMed
    1. Flanagan S., McKee E.E., Das D. Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function. Antimicrob. Agents Chemother. 2015;59(1):178–185. - PMC - PubMed
    1. Lee M., Lee J., Carroll M.W. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N. Engl. J. Med. 2012;367(16):1508–1518. (Oct 18) - PMC - PubMed

MeSH terms

LinkOut - more resources